Repligen Corp
NASDAQ:RGEN
Repligen Corp
NASDAQ:RGEN
Price:
115.11
USD
0.8%
Market Cap:
$6.5B
Relative Value
The Relative Value of one
RGEN
stock under the Base Case scenario is
hidden
USD.
Compared to the current market price of 115.11 USD,
Repligen Corp
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
RGEN Relative Value
HIDDEN
Multiples Across Competitors
RGEN Competitors Multiples
Repligen Corp Competitors
Repligen Corp Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Repligen Corp
NASDAQ:RGEN
|
6.5B USD | 8.8 | 132.6 | 45.4 | 105.6 | |
| US |
P
|
PerkinElmer Inc
LSE:0KHE
|
948.1B USD | 332 | 3 930.8 | 1 126.4 | 2 169.1 | |
| US |
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
179.2B USD | 4 | 26.7 | 18.6 | 25 | |
| US |
|
Danaher Corp
NYSE:DHR
|
138.2B USD | 5.6 | 38.3 | 19.5 | 28.3 | |
| KR |
|
Samsung Biologics Co Ltd
KRX:207940
|
82.3T KRW | 18.1 | 46.1 | 30.1 | 39.4 | |
| CH |
|
Lonza Group AG
SIX:LONN
|
33.5B CHF | 5.1 | 35.4 | 26.4 | 26.4 | |
| CN |
|
WuXi AppTec Co Ltd
SSE:603259
|
265.1B CNY | 6 | 17.7 | 17.7 | 17.7 | |
| US |
|
Agilent Technologies Inc
NYSE:A
|
31.6B USD | 4.6 | 25 | 19.6 | 23.4 | |
| US |
|
Waters Corp
NYSE:WAT
|
28.9B USD | 9.1 | 44.8 | 29 | 36.4 | |
| US |
|
IQVIA Holdings Inc
NYSE:IQV
|
28B USD | 1.8 | 21.2 | 11.8 | 17.8 | |
| US |
|
Mettler-Toledo International Inc
NYSE:MTD
|
24.7B USD | 6.2 | 28.6 | 21.3 | 23.6 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
